Cases 1 - 10 of 8,822
Sandoz Inc. v. Boehringer Ingelheim Pharmaceuticals Inc. et al
as 1:2024cv01192
Defendant:
Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals Inc.
Plaintiff:
Sandoz Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. ANOBRI PHARMACEUTICALS US, LLC et al
as 2:2024cv09135
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. and BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Defendant:
NANCHANG ANOVENT PHARMACEUTICAL CO., LTD., SHANGHAI ANOVENT PHARMACEUTICAL CO., LTD. and ANOBRI PHARMACEUTICALS US, LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2024cv00082
Defendant:
Mylan Pharmaceuticals Inc., Mylan Laboratories Limited and Mylan Inc.
Plaintiff:
Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Counter-Claimant:
Mylan Pharmaceuticals Inc., Mylan Laboratories Limited and Mylan Inc.
Counter-Defendant:
Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Granules India Limited
as 1:2024cv00753
Plaintiff:
Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH and others
Defendant:
Granules India Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Apotex Inc. v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
as 1:2024cv00577
Plaintiff:
Apotex Inc.
Defendant:
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
1199SEIU National Benefit Fund et al v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
as 3:2024cv00783
Plaintiff:
1199SEIU National Benefit Fund, 1199SEIU Greater New York Benefit Fund, 1199SEIU National Benefit Fund for Home Care Workers and others
Defendant:
Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 15 U.S.C. § 15 Antitrust Litigation
Contreras v. GlaxoSmithKline LLC et al
as 9:2024cv80462
Plaintiff:
Jorge Contreras
Defendant:
Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Promeco S.A .de C.V. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Massachusetts Laborers' Health & Welfare Fund v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
as 1:2024cv10565
Plaintiff:
Massachusetts Laborers' Health & Welfare Fund
Defendant:
Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim International GMBH
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
Lee v. Boehringer Ingelheim International GMBH et al
as 3:2024cv00050
Plaintiff:
Adam Lee
Defendant:
Boehringer Ingelheim International GMBH, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Promeco S.A. de C.V. and others
Cause Of Action: 28 U.S.C. § 1446 pl Petition for Removal - Product Liability
Grasberger-Baty et al v. GlaxoSmithKline Holdings (Americas) Inc. et al
as 3:2024cv00049
Plaintiff:
Nancy Grasberger-Baty and Williams Baty
Defendant:
GlaxoSmithKline Holdings (Americas) Inc., GlaxoSmithKline LLC, GlaxoSmithKline PLC and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
